These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 13129653)

  • 1. Selective deficit of hippocampal N-acetylaspartate in antipsychotic-naive patients with schizophrenia.
    Fannon D; Simmons A; Tennakoon L; O'Céallaigh S; Sumich A; Doku V; Shew C; Sharma T
    Biol Psychiatry; 2003 Sep; 54(6):587-98. PubMed ID: 13129653
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Atypical antipsychotic drug treatment for 6 months restores N-acetylaspartate in left prefrontal cortex and left thalamus of first-episode patients with early onset schizophrenia: A magnetic resonance spectroscopy study.
    Gan JL; Cheng ZX; Duan HF; Yang JM; Zhu XQ; Gao CY
    Psychiatry Res; 2014 Jul; 223(1):23-7. PubMed ID: 24831926
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multiregional 1H-MRSI of the hippocampus, thalamus, and basal ganglia in schizophrenia.
    Ende G; Braus DF; Walter S; Weber-Fahr W; Henn FA
    Eur Arch Psychiatry Clin Neurosci; 2003 Feb; 253(1):9-15. PubMed ID: 12664307
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Common pattern of cortical pathology in childhood-onset and adult-onset schizophrenia as identified by proton magnetic resonance spectroscopic imaging.
    Bertolino A; Kumra S; Callicott JH; Mattay VS; Lestz RM; Jacobsen L; Barnett IS; Duyn JH; Frank JA; Rapoport JL; Weinberger DR
    Am J Psychiatry; 1998 Oct; 155(10):1376-83. PubMed ID: 9766769
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regional proton magnetic resonance spectroscopy in schizophrenia and exploration of drug effect.
    Heimberg C; Komoroski RA; Lawson WB; Cardwell D; Karson CN
    Psychiatry Res; 1998 Aug; 83(2):105-15. PubMed ID: 9818736
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prediction of functional outcome 18 months after a first psychotic episode: a proton magnetic resonance spectroscopy study.
    Wood SJ; Berger GE; Lambert M; Conus P; Velakoulis D; Stuart GW; Desmond P; McGorry PD; Pantelis C
    Arch Gen Psychiatry; 2006 Sep; 63(9):969-76. PubMed ID: 16952999
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of Metabolite Concentrations in the Left Dorsolateral Prefrontal Cortex, the Left Frontal White Matter, and the Left Hippocampus in Patients in Stable Schizophrenia Treated with Antipsychotics with or without Antidepressants. ¹H-NMR Spectroscopy Study.
    Strzelecki D; Grzelak P; Podgórski M; Kałużyńska O; Stefańczyk L; Kotlicka-Antczak M; Gmitrowicz A
    Int J Mol Sci; 2015 Oct; 16(10):24387-402. PubMed ID: 26501256
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hippocampal neuronal dysfunction in schizophrenia as measured by proton magnetic resonance spectroscopy.
    Deicken RF; Zhou L; Schuff N; Fein G; Weiner MW
    Biol Psychiatry; 1998 Apr; 43(7):483-8. PubMed ID: 9547926
    [TBL] [Abstract][Full Text] [Related]  

  • 9. N-acetylaspartate reduction in the medial prefrontal cortex following 8 weeks of risperidone treatment in first-episode drug-naïve schizophrenia patients.
    Zong X; Hu M; Li Z; Cao H; He Y; Liao Y; Zhou J; Sang D; Zhao H; Tang J; Lv L; Chen X
    Sci Rep; 2015 Mar; 5():9109. PubMed ID: 25778460
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cognitive impairment and in vivo metabolites in first-episode neuroleptic-naive and chronic medicated schizophrenic patients: a proton magnetic resonance spectroscopy study.
    Ohrmann P; Siegmund A; Suslow T; Pedersen A; Spitzberg K; Kersting A; Rothermundt M; Arolt V; Heindel W; Pfleiderer B
    J Psychiatr Res; 2007 Oct; 41(8):625-34. PubMed ID: 16949099
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Decreased left frontal lobe N-acetylaspartate in schizophrenia.
    Deicken RF; Zhou L; Corwin F; Vinogradov S; Weiner MW
    Am J Psychiatry; 1997 May; 154(5):688-90. PubMed ID: 9137129
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hippocampal N-acetyl aspartate in unaffected siblings of patients with schizophrenia: a possible intermediate neurobiological phenotype.
    Callicott JH; Egan MF; Bertolino A; Mattay VS; Langheim FJ; Frank JA; Weinberger DR
    Biol Psychiatry; 1998 Nov; 44(10):941-50. PubMed ID: 9821558
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduced concentrations of thalamic N-acetylaspartate in male patients with schizophrenia.
    Deicken RF; Johnson C; Eliaz Y; Schuff N
    Am J Psychiatry; 2000 Apr; 157(4):644-7. PubMed ID: 10739431
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proton magnetic resonance spectroscopy of the medial prefrontal cortex in patients with deficit schizophrenia: preliminary report.
    Delamillieure P; Fernandez J; Constans JM; Brazo P; Benali K; Abadie P; Vasse T; Thibaut F; Courthéoux P; Petit M; Dollfus S
    Am J Psychiatry; 2000 Apr; 157(4):641-3. PubMed ID: 10739430
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lower concentration of hippocampal N-acetylaspartate in familial bipolar I disorder.
    Deicken RF; Pegues MP; Anzalone S; Feiwell R; Soher B
    Am J Psychiatry; 2003 May; 160(5):873-82. PubMed ID: 12727690
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Supplementation of antipsychotic treatment with sarcosine – GlyT1 inhibitor – causes changes of glutamatergic (1)NMR spectroscopy parameters in the left hippocampus in patients with stable schizophrenia.
    Strzelecki D; Podgórski M; Kałużyńska O; Gawlik-Kotelnicka O; Stefańczyk L; Kotlicka-Antczak M; Gmitrowicz A; Grzelak P
    Neurosci Lett; 2015 Oct; 606():7-12. PubMed ID: 26306650
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of treatment with antipsychotic drugs on brain N-acetylaspartate measures in patients with schizophrenia.
    Bertolino A; Callicott JH; Mattay VS; Weidenhammer KM; Rakow R; Egan MF; Weinberger DR
    Biol Psychiatry; 2001 Jan; 49(1):39-46. PubMed ID: 11163778
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A 1H-MRS investigation of the medial temporal lobe in antipsychotic-naïve and early-treated first episode psychosis.
    Wood SJ; Berger GE; Wellard RM; Proffitt T; McConchie M; Velakoulis D; McGorry PD; Pantelis C
    Schizophr Res; 2008 Jul; 102(1-3):163-70. PubMed ID: 18456460
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The hippocampus in patients treated with electroconvulsive therapy: a proton magnetic resonance spectroscopic imaging study.
    Ende G; Braus DF; Walter S; Weber-Fahr W; Henn FA
    Arch Gen Psychiatry; 2000 Oct; 57(10):937-43. PubMed ID: 11015811
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lower concentration of thalamic n-acetylaspartate in patients with schizophrenia: a replication study.
    Ende G; Braus DF; Walter S; Henn FA
    Am J Psychiatry; 2001 Aug; 158(8):1314-6. PubMed ID: 11481168
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.